Literature DB >> 10509639

Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma.

T Mäkitie1, P Summanen, A Tarkkanen, T Kivelä.   

Abstract

PURPOSE: Although malignant uveal melanoma disseminates predominantly hematogenously because of the absence of intraocular lymphatics, consensus about prognostic impact of microvascular density (MVD) has not been reached. This study was undertaken to investigate whether MVD, microvascular patterns, or both determine prognosis of uveal melanoma.
METHODS: A population-based retrospective cohort study of melanoma-specific and all-cause mortality of 167 consecutive patients who had an eye enucleated because of choroidal or ciliary body melanoma from 1972 through 1981 was conducted. MVD was determined by counting tumor vessels in a masked fashion from areas of highest vessel density after immunostaining for CD34 epitope, factor VIII-related antigen (FVIII-RAg), and alpha-smooth muscle actin (SMA). Kaplan-Meier and Cox regression analyses of survival were performed. The association between MVD and tumor size and location, cell type, and microvascular patterns was assessed.
RESULTS: MVD could be determined from 134 of 167 melanomas (80%). Based on globally highest count obtained with antibodies to CD34, MVD ranged from 5 to 121 vessels/0.313 mm2 (median, 40) and its association with presence of microvascular loops and networks (P = 0.0006), epithelioid cells (P = 0.028), and largest basal tumor diameter (P = 0.0029) was statistically significant. The 10-year melanoma-specific mortality increased with MVD (0.09, 0.29, 0.59, and 0.64, according to quartiles; P < 0.0001), as did all-cause mortality (P = 0.0022). Equivalent results were obtained with immunostaining for FVIII-RAg, whereas MVD obtained with antibodies to SMA was not associated with prognosis. Cox regression showed a hazard ratio of 2.45 (95% CI, 1.43-4.18) for presence of epithelioid cells, 1.11 (95% CI, 1.03-1.20) for largest basal diameter, 1.23 (95% CI, 1.06-1.43) for square root-transformed MVD, and 1.51 (95% CI, 1.09-2.10) for presence of loops and networks, all of which independently contributed to prognosis.
CONCLUSIONS: The findings support the theory that both MVD and microvascular patterns contribute independently to prognosis in uveal melanoma in addition to cell type and size of the tumor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10509639

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  25 in total

Review 1.  Vasculogenic mimicry: how convincing, how novel, and how significant?

Authors:  D M McDonald; L Munn; R K Jain
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

2.  A pilot study of bevacizumab and interferon-α2b in ocular melanoma.

Authors:  Kristan D Guenterberg; Valerie P Grignol; Kiran V Relekar; Kimberly A Varker; Helen X Chen; Kari L Kendra; Thomas E Olencki; William E Carson
Journal:  Am J Clin Oncol       Date:  2011-02       Impact factor: 2.339

3.  Comparing vasculogenic mimicry with endothelial cell-lined vessels: techniques for 3D reconstruction and quantitative analysis of tissue components from archival paraffin blocks.

Authors:  Amy Y Lin; Zhuming Ai; Sang-Chul Lee; Peter Bajcsy; Jacob Pe'er; Lu Leach; Andrew J Maniotis; Robert Folberg
Journal:  Appl Immunohistochem Mol Morphol       Date:  2007-03

4.  Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis.

Authors:  T G Sheidow; P L Hooper; C Crukley; J Young; J G Heathcote
Journal:  Br J Ophthalmol       Date:  2000-07       Impact factor: 4.638

5.  Prognostic significance of PD-1/PD-L1 expression in uveal melanoma: correlation with tumor-infiltrating lymphocytes and clinicopathological parameters.

Authors:  Lata Singh; Mithalesh Kumar Singh; Maria Cristina Kenney; Martine J Jager; Moshahid Alam Rizvi; Rachna Meel; Neiwete Lomi; Sameer Bakhshi; Seema Sen; Seema Kashyap
Journal:  Cancer Immunol Immunother       Date:  2020-11-02       Impact factor: 6.968

6.  Targeting pericytes diminishes neovascularization in orthotopic uveal melanoma in nerve/glial antigen 2 proteoglycan knockout mouse.

Authors:  Ugur Ozerdem
Journal:  Ophthalmic Res       Date:  2006-07-28       Impact factor: 2.892

7.  Antitumor activity of Endostar combined with radiation against human nasopharyngeal carcinoma in mouse xenograft models.

Authors:  Juying Zhou; Lili Wang; Xiaoting Xu; Yu Tu; Songbing Qin; Yuzhen Yin
Journal:  Oncol Lett       Date:  2012-08-08       Impact factor: 2.967

Review 8.  Vasculogenic mimicry and tumor angiogenesis.

Authors:  R Folberg; M J Hendrix; A J Maniotis
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

Review 9.  Prognostication in eye cancer: the latest tumor, node, metastasis classification and beyond.

Authors:  T Kivelä; E Kujala
Journal:  Eye (Lond)       Date:  2012-12-21       Impact factor: 3.775

10.  Blood vessel maturation in human uveal melanoma: spatial distribution of neovessels and mature vasculature.

Authors:  Yolanda Piña; Colleen M Cebulla; Timothy G Murray; Armando Alegret; Sander R Dubovy; Hinda Boutrid; William Feuer; Lejla Mutapcic; Maria-Elena Jockovich
Journal:  Ophthalmic Res       Date:  2009-03-26       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.